General Surgery Devices Market Worth $26.5 Billion By 2026

The global general surgery devices market size is expected to reach USD 26.5 billion by 2026 registering a CAGR of 8.5%, according to a new report by Grand View Research, Inc. Increasing number of surgical procedures being performed coupled with technological advancements is anticipated to drive the market. Moreover, rising awareness and patient affordability for plastic or reconstructive surgeries would propel the number of procedures conducted during the forecast period.

Global health initiatives for the advanced surgical procedure is expected to boost the market. In January 2017, Ethiopia Federal Ministry of Health (FMOH) launched the Health Sector Transformation Plan (HSTP) and Safe Surgery (SaLTS) program that prioritizes safe surgery and makes anesthesia care and emergency surgical services accessible and affordable.

Technological advancements are also contributing to the market growth. Several key companies are investing in R&D for the development of innovative products. For instance, development of medical robots to assist surgeons is a key advancement in the field. Medical robots offer several advantages, such as a 3D view of the operating field, reduced blood loss & transfusions, lower risk of infection, faster recovery time, minimal scarring, and high precision.

Furthermore, growing aging population and cases of road accidents and increased healthcare expenditure in emerging economies are likely to boost the market during the forecast period. According to the WHO, the world’s population aged 60 years and above is expected to reach 2 billion by 2050 from 900 million in 2015. Geriatric population is more susceptible to a number of diseases, which is likely to increase the need for effective treatments, thereby driving the market.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/general-surgery-devices-market

Further key findings from the study suggest:

Disposable surgical supplies held the largest market share in 2018. Low product cost and regulatory support for the usage of disposable products is expected to fuel the demand for these devices
Asia Pacific is estimated to expand at the highest CAGR over the forecast period due to technological advancements, increasing investments and improving reimbursement scenario along with the growing medical tourism sector in the region
Medical robotics & computer-assisted surgery devices are projected to witness the maximum CAGR of 9.9% from 2019 to 2026 due to increasing R&D investments and availability of technologically advanced products
Some of the key companies in the market are Medtronic plc; Johnson & Johnson Services, Inc.; CONMED Corp.; Becton, Dickinson and Company (BD); B Braun Melsungen AG; Strykers; Boston Scientific Corp.; Erbe Elektromedizin GmbH; and The 3M Company

Lymphoma Treatment Market Size Worth $26.4 Billion By 2026

The global lymphoma treatment market size is expected to reach USD 26.4 billion by 2026, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 9.5%. Rising research activities for development of new treatments and increasing product line extension are likely to expedite growth. Increasing commercialization of novel drugs are further expected to drive the growth.

Availability of wide variety of products is further expected to aid growth. For instance, in January 2019, BeiGene received a breakthrough therapy designation by the U.S. FDA for its product Zanubrutinib for treating mantle cell lymphoma in adults. This drug is currently in late-stage clinical trial and is expected to be launched during the forecast period.

Growing awareness about early diagnosis of lymphoma among healthcare professionals & patients and rising government funding for R&D are some factors expected to propel market growth. For instance, institutes such as National Cancer Institute receives funding from the U.S. Congress to support cancer-related research and associated activities.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/lymphoma-market

Further key findings from the report suggest:

Non-Hodgkin lymphoma held the largest share in 2018 owing to prevalence of non-Hodgkin lymphoma and presence of blockbuster drugs.
Hodgkin lymphoma is expected to be the fastest growing segment due to presence of strong product pipeline and increase in the number of label extension for existing drugs.
Based on drug, Revlimid held the highest share in 2018 and is expected to grow at a significant rate during the forecast period. This can be attributed to growing use of this product in cancer treatment regimens.
Rituxan/MabThera held the second largest share in 2018 owing to increasing use of this product in multiple indications and high prescription rate in major markets such as the U.S., Europe, and Japan.
North America dominated in 2018, followed by Europe. This can be attributed to well-established healthcare infrastructure, high R&D expenditure, availability of novel drugs, and presence of key players.
Asia Pacific is expected to be the fastest growing over the forecast period owing to increase in commercialization of products, rise in awareness about diseases and high unmet clinical needs.
Some of the major players are Celgene Corporation; Bristol-Myers Squibb Company; F. Hoffmann-La Roche Ltd.; Seattle Genetics, Inc.; Merck & Co., Inc.; Johnson & Johnson; Takeda Pharmaceutical Company Ltd.; Abbott Laboratories; and Eli Lilly and Company.
Key players for lymphoma treatment market are adopting strategies such as collaborations, mergers & acquisitions, product development, product line extension, and regional expansion to increase their share. For instance, Seattle Genetics collaborated with Takeda Pharmaceuticals for commercialization of Adcetris in different regions other than North America.

Preimplantation Genetic Testing Market Worth $107.3 Million By 2024

The global preimplantation genetic testing market is expected to reach USD 107.3 million by 2024, at a CAGR of 6.2% over the forecast period, according to a new report by Grand View Research, Inc. It is primarily driven by a rising awareness among couples to undergo diagnostic and screening tests to minimize genetic diseases and aneuploidy in fetus. The ability of preimplantation genetic testing to detect genetic disorders and rare diseases, such as fibrodysplasia ossificans progressive, is anticipated to propel the growth.

High adoption of In Vitro Fertilization (IVF) technique consequently upsurges the utilization of Preimplantation Genetic Diagnosis (PGD). These techniques are advantageous in a way that they allow the development of a healthy fetus and prevent the risk of selective pregnancy termination. Hence, PGT acts as an addendum to assisted reproductive technology.

A substantial number of patients with infertility and impaired fecundity are recommended to embrace IVF therapy in combination with PGT procedures, which in turn is expected to stimulate the growth. In addition, public and private authorities are promoting reproductive health by undertaking initiatives is also anticipated to drive the Preimplantation Genetic Testing (PGT) (PGS/PGD) market.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/preimplantation-genetic-testing-pgt-market

Further key findings from the report suggest:

Availability of a significant number of services related to early diagnosis of specific gene mutation in embryo marked the dominant position of PGD in 2018
Preimplantation Genetic Screening (PGS) seems to be reasonable intervention to enhance efficiency of selecting chromosomally normal embryo during IVF cycles. It is increasingly being applied for embryo screening due to ever-expanding IVF, which is projected to create lucrative growth opportunities in near future
Advancements in detection of chromosomal anomalies by executing non-invasive prenatal testing results in a maximum share of this segment in 2018
Expanding utilization rate of FISH probe sets and benefits associated with the detection of a single-gene disorder is expected to fuel the growth of X-linked diseases segment
Implementation of PGT in embryo HLA typing for stem cell therapy is expected to impose segment growth. This is further attributed to the advantages pertaining to PGS testing for identification of HLA compatible embryos during stem cell therapy
Europe accounts for largest revenue share in 2018 owing to increased usage of PGD and PGS for the delivery of genetically healthy offspring during IVF procedures
Asia Pacific market is observed to reveal the fastest CAGR due to the rise in medical tourism and the continuous development of IVF and PGD clinics in Asian countries
Key players that have commercialized PGT services include Natera, Inc.; CooperSurgical, Inc.; F. Hoffmann-La Roche AG; Illumina, Inc.; IGENOMIX; and others
Key participants are actively involved in expansion of the distribution network for their products as well as R&D activities for the development of novel PGT services. In October 2018, Illumina Inc. signed an agreement with Vitrolife AB under which Vitrolife act as a distributor supplier of Illumina’s PGT products in EMEA and America.

Europe MRO Distribution Market Size Worth $222.11 Billion By 2028

The Europe MRO distribution market size is expected to reach USD 222.11 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 1.6% from 2021 to 2028. The rise in scheduled maintenance and increasing investments in repair operations are expected to ascend the market growth over the forecast period.

Prominent European industries have adopted integrated repair, maintenance, and operation service concepts for improvements in the equipment and services in critical operations. Many industrial units adopted this change post-recession period and are likely to continue in the projected time. Therefore, the demand for Maintenance, Repair, & Overhaul (MRO) distribution is expected to remain high.

The untapped markets are benefitted owing to the emergence of e-commerce platforms in the European region, thus the penetration of MRO products in the region has escalated. Moreover, the established players in the region have adopted the strategy of acquiring small-scale players to enhance the market presence.

Major players in the regional market are employing several strategies focusing on digital marketing, pricing, product placement, and communication to improve supply channels and enhance sales operations. These enhanced sales processes and standardized sales tools are anticipated to upscale the MRO industry growth in the upcoming future.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/europe-maintenance-repair-overhaul-mro-distribution-market

Further key findings from the study suggest:

The machine consumables product segment accounted for the largest share of 30.2% in 2020 on account of the increasing focus of the end-users on the maintenance and upkeep of critical equipment in order to maintain and enhance their performance and operational lifetime
The external MRO service type segment is anticipated to witness the fastest growth from 2021 to 2028 owing to the increasing contracts to third-party MRO service providers by the product manufacturers to increase the geographical operation
The preventive/scheduled maintenance type segment accounted for the largest share of 58.8% in 2020 and is projected to witness significant growth over the forecast period owing to its rising adoption in order to reduce the breakdown and maintenance time
The machinery and equipment application segment is projected to expand at the fastest CAGR from 2021 to 2028 on account of the growing demand from a diverse range of industry verticals, including construction, automotive, and metalworking
Germany accounted for the largest share of 21.8% in 2020 owing to the high adoption of preventive and scheduled MRO among the manufacturers operating in the country

Gaming Peripherals Market Worth $6.96 Billion By 2025

The global gaming peripheral market size is expected to reach USD 6.96 billion by 2025, registering a CAGR of 10.4% from 2020 to 2025, according to a new report by Grand View Research, Inc. The increasing number of online gamers and hardware improvements such as faster processors, graphics and sound cards has enabled a wider scope for the industry. In addition, the industry is also witnessing a high influx of revenue based on a high consumer spending for ultra-modern games. In the past two decades video games have progressed through many stages as gaming consoles have become more sophisticated in the recent years.

The scope of gaming hardware market has gone to a vast extent encompassing a lot of diversity of applications. To supplement the growth factors, investment is one of the value chain components that features the game or a large corporation dealing with large-budgets. On contrary, independent developers may also opt to fund their own platforms. Ongoing innovations are further expected to drive the market growth. For instance, in October 2019, Logitech G, a brand of Logitech introduced PRO X mechanical gaming keyboard that comes with swappable switches as a part of personalization. The new keyboard is a better choice for Esports professionals that exhibits a high reliability and features in enhanced designing.

Asia Pacific is expected to witness a rapid growth attributing to wide popularity of video games and high preference for entertainment and online gaming. India being a huge market for online gaming is gaining traction as digitalization is at its peak. Government initiatives such as ‘Skill India’ and ‘Make in India’ have been encouraging the development of gaming peripherals and entertainment industry. In addition, Indian consumers possess a huge liking for online games and are inclined toward spending on these peripherals.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/gaming-peripherals-market

Further key findings from the report suggest:

The headsets segment is expected to expand at the highest CAGR from 2019 to 2025. The introduction of advanced features such as multiple connectivity option, noise canceling technology, adjustable controls, and high audio quality driving demand for headsets segment
The gaming consoles segment is expected to register the highest CAGR over the forecast period. This growth can be attributed to the introduction of consoles with wireless connectivity and increasing number of gamers globally
Wired segment is still a predominant aspect of technological growth as there is a robust demand for DVD games and other hardware such as joystick, mouse, and other peripherals
Online distribution is expected to gain a strong growth as developers now focus on developing their own platforms for release and distribution
North America held the largest market share in 2019 and is expected to maintain its dominance over the forecast period. Growing demand for advanced gaming peripherals such as wireless keyboard and mouse, 4K gaming console, and wireless headsets with noise cancellation technology for enhanced gaming experience is expected to drive the growth

E-commerce Software Market Size Worth $20.6 Billion By 2027

The global e-commerce software market size is expected to reach USD 20.6 billion by 2027, expanding at a CAGR of 16.3% from 2020 to 2027, according to a study conducted by Grand View Research, Inc. E-commerce software is used by organizations to offer their products and services online. Various benefits such as cost reduction, enhanced customer experience, and efficient management of inventory is enabling companies to move their business online. This is expected to positively impact growth over the forecast period.

Increasing adoption of online shopping in developing economies is also anticipated to boost market growth during the forecast period. According to the India Brand Equity Foundation (IBEF), the number of online shoppers in India is projected to reach around 220.0 million by 2025. Furthermore, with the introduction of 5G technology, online shopping is anticipated to rise over the coming years. Due to this upsurge, retailers are opting for solutions to meet the customer requirements, efficiently.

E-commerce software portals play a pivotal role, help SMEs and large-scale enterprises reach remote areas, and are gradually becoming a way of doing business worldwide. These portals facilitate in establishing new trading relationships between companies in addition to supporting existing relationships. Moreover, e-commerce platforms enable businesses to lower down their marketing expenses, better management of the suppliers and customers, and boosts sales engagement.

Additionally, rising proliferation of smartphones and increasing internet penetration is further creating avenues for market growth. Owing to the ease of doing business and enabling companies to track their inventory, view orders, and payments on mobile phones has resulted in increased adoption of e-commerce platforms. Furthermore, with increasing competition, several businesses are opting for online business models to gain a competitive edge in the market.

The outbreak of COVID-19 pandemic has resulted in an unprecedented impact on the global economy. People across the globe have shifted to online shopping of groceries and healthcare products as brick-and-mortar stores are shut-down to combat the virus spread. Market players are focusing on offering investments for retailers to start their business online. For instance, 3dcart introduced its COVID-19 e-commerce Assistance Fund plan committing USD 2.5 million for small businesses that are planning to bring their operations online. It is expected that the online shopping trend will continue over the long-term, due to which the market will rise.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/e-commerce-software-market

Further key findings from the study suggest:

The cloud segment is projected to witness the fastest CAGR exceeding 15.0% over the forecast period. This upsurge is attributed to the increasing adoption of cloud-based technology across various industry verticals
The apparel and fashion segment held the largest market share of 30.8% in 2019. This share is due to the rising number of web-only merchants in the apparel sector
Asia Pacific is estimated to witness the fastest CAGR of over 16.0% during 2020 to 2027 due to the digitalization initiatives taken by governments of various countries such as India and China.

Next Gen Sequencing Data Analysis Market Worth $1.5 Billion By 2027

The global next gen sequencing data analysis market size is expected to reach USD 1.5 billion by 2027, expanding at a CAGR of 12.9%, according to a new report by Grand View Research, Inc. Next generation sequencing (NGS) has transformed the field of proteomic and genomic research as the technology is highly accurate, offering higher throughput and used for a variety of applications. This includes de novo assembly, transcriptome, whole-genome sequencing, and resequencing for DNA and RNA. Hence, the high adoption of NGS by academic and clinical settings for genomic and proteomic research drives the demand for NGS data analysis tools.

Numerous tools, such as EpiGentek’s Targeted Methyl-Seq platform and Agilent’s HaloPlex capture system, are used to determine DNA methylation profiles across any individual genome. Bisulfite-methylation mapping of whole-genome is currently a feasible technique for targeted sequencing. Besides, expansion of targeted methylation NGS analysis by techniques such as Single Molecule Real-Time Bisulfite Sequencing is driving the market.

Epigentek Group, Inc.; Novogene Co., Ltd.; and CD Genomics are among the few companies that provide services related to targeted bisulfite or methylation sequencing data analysis. Furthermore, key companies are constantly expanding their product line to suffice significant upswing in the demand for these solutions globally. For instance, in July 2020, Pacific Biosciences introduced SMRT Link v9.0 software that is compatible with its Sequel II System.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/next-generation-sequencing-ngs-data-analysis-market

Further key findings from the report suggest:

Analytical software is expected to witness significant growth over the forecast period due to the high demand for data management software for managing a large amount of sequenced information
QIAGEN’s CLC Genomics Workbench is one such solution that is a complete toolkit for analyzing transcriptomics, metagenomics, genomics, and epigenomics in one single program
The NGS tertiary data analysis segment held the largest share for workflows in 2019 as it involves the usage of numerous tools
In addition, the tertiary step is an experiment-specific, complex, and time-consuming step of NGS workflow
Availability of software and tools, such as PolyPhen, SIFT, and CIViC, for variant interpretation and annotation, is attributive to the larger share of the segment
The outsourced mode segment has gained immense popularity as it minimizes the requirement of expensive computational infrastructure and complex software tools
SciBerge.Kfm, a German firm, offers outsourced analyzing services to allow its users to interpret NGS information in a fraction of the total price incurred for deep sequencing and DNA library preparation
The wide availability of algorithms and alignment tools for analyzing whole-genome, amplicon, 16S rRNA, methylation, and tumor-normal sequenced data contributes to the dominant revenue share of the short-read segment in 2019
TopHat, Bowtie2, STAR, BWA, Minimap2, and HISAT2 are the commonly used alignment tools for high-throughput short-read sequencing
The academic research end-use segment dominated the market in terms of revenue share in 2019
The rise in the number of skilled professionals, usage of NGS computational tools, and availability of on-site bioinformatics courses and training programs contribute to a larger revenue share
North America dominated the market in 2019 in terms of revenue generation
The launch of large-scale projects to sequence genome, high demand for personalized medicine, constant approval, and favorable reimbursement policies for NGS-based diagnostic tests are among few factors attributive for the region’s larger share
Major market participants have undertaken strategic initiatives to expand the scope of NGS computational tools
For instance, in October 2019, Thermo Fisher signed an agreement with Genialis and integrated its Invitrogen Collibri Stranded RNA Library Prep Kit with Genialis Expressions analysis software to ease the evaluation of RNA sequenced data.

Microfluidics Market Size Worth $31.6 Billion By 2027

The global microfluidics market size is expected to reach USD 31.6 billion by 2027, according to a new report by Grand View Research, Inc., registering an 11.3% CAGR over the forecast period. Demand for microfluidic-based devices is expected to surge owing to introduction of novel technologies such as digital microfluidics. These techniques allow on-chip biochemical analysis, thereby driving adoption.

Rise in the adoption of microfluidics for point-of-care diagnostics is expected to have a significant impact on market growth. Industry players such as Abbott, Roche, and Danaher have already incorporated this technology in their existing diagnostic devices and are exploring the scope of digital microfluidics. For instance, Philips’ Minicare I-20 handheld device provides accurate and rapid results for the diagnosis of heart attacks.

Large investments targeted toward the development of microfluidics and promoting their adoption are expected to create opportunities for the expansion for automated as well as miniature devices. For instance, according to an article published in 2018, there have been large-scale investments in “sample-to-answer” microfluidic automated testing in recent years.

Microfluidics has not only been proven beneficial in biological bench-work but also several medical and pharmaceutical applications, including diagnosis of infectious diseases and treatment of cancer. The technology aids in the fabrication of functional living tissues and artificial organs. Companies such as Abbott, Roche, Cepheid, and Becton, Dickinson and Company (BD) are integrating such technologies with in-vitro diagnostics (IVD). Samsung LABGEOPT10 and Abbott i-STAT are examples of single-step blood glucose testing assays that can work on a small sample volume (a single blood drop).

Click the link below:
https://www.grandviewresearch.com/industry-analysis/microfluidics-market

Further key findings from the report suggest:

The medical/healthcare segment dominated the market by technology owing to rise in demand for new molecular diagnostic tests with enhanced sensitivities, shorter turnaround time, and increased accuracy at minimal costs
PCR & RT-PCR were the largest revenue-generating medical technology in 2019 and the segment is expected to retain its lead throughout the forecast period. Digital PCR in combination with a microfluidic device allows a large amount of PCR reaction mix to be distributed into nanoliter-sized volumes automatically
The organs-on-chips application segment is expected to register the fastest CAGR throughout the forecast period. The method can potentially reduce the failure rate in drug development pipelines, thereby reducing the time and money associated with drug development
By material, polydimethylsiloxane (PDMS) accounted for the largest revenue share in 2019. The material is used to fabricate microfluidic-based devices because of its nontoxicity, robustness, optical transparency, permeability, biocompatibility, elastomeric features, and low cost.
North America dominated the global microfluidics market in 2019 and is expected to retain its dominance over the analysis period. Local presence of leading players, availability of funds and research capital, and launch of novel sample volume screening technologies drives the North America market
Asia Pacific is expected to witness the fastest growth owing to rise in aging population, demand for point-of-care diagnostic tests, and presence of academic institutions such as the Institute of Microchemical Technology (IMT), Japan, that are focused on microfluidic-based research
Illumina, Inc.; PerkinElmer, Inc.; Agilent Technologies, Inc.; Danaher Corporation; Bio-Rad Laboratories, Inc.; Life Technologies Corporation; Abbott Laboratories; F. Hoffmann-La Roche Ltd; and Fluidigm Corporation are some of the key players operating in the global market

Enteral Feeding Formulas Market Size Worth $8.72 Billion By 2027

The global enteral feeding formulas market size is expected to reach USD 8.72 billion by 2027, according to a new report by Grand View Research, Inc., expanding at a CAGR of 6.0% from 2020 to 2027. Increasing prevalence of diseases such as diabetes, cancer, dementia, multiple sclerosis, chronic liver disease and COPD is expected to boost the demand for enteral products that aid patients having trouble in oral intake. As per a study published by Cancer Research U.K., approximately 17.0 million new cancer cases were reported in 2018 across the globe. Incidence of cancer is projected to increase by 62% between 2018 and 2040.

In addition, growing deficiency of macro and micro nutrients among the patients in hospitals during pre and post-surgery drives the demand for enteral feeding formulas. Furthermore, increasing product offerings aimed at specific indications are delivering targeted nutritional needs, which is a key driver of this market. These enteral tube feeds usually contain polysaccharides and proteins for patients capable of digesting and absorbing nutrients without any difficulty. Availability of wide varieties of enteral formulas, along with increased demand for low-cost nutrient formulations among consumers, is boosting the market growth. Moreover, favorable reimbursement scenario supports high adoption of tube feeds among hospital patients as the enteral nutrition is usually covered under Medicare claims.

Moreover, the market is consolidated with presence of few leading players, including Nestle Health Science, Abbott, and Danone. These players are constantly investing in the R&D activities for development of enhanced products that cater to the niche therapeutic areas having high growth potential in the industry in order to gain a competitive edge. Market entry has proved to be challenging for new entrants as the industry is dominated by few major MNCs with high brand recognitions.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/enteral-feeding-formulas-market

Further key findings from the report suggest:

Standard formula emerged as the leading product segment in 2019 with a revenue share of 54.3% in the global market
By flow type, intermittent feeding flow accounted for the largest revenue share in 2019. Continuous feeding flow is projected to expand at the fastest CAGR during the forecast period
The adults stage segment accounted for the largest revenue share in 2019 owing to growing demand for such nutrition formulations in the adult population
Others emerged as the leading indication segment in 2019 with a revenue share of 41.9% in the global market
Home care emerged as the leading end user segment in 2019 and is expected to witness significant growth over the forecast period
North America accounted for the largest share in 2019 due to growing preference for home-based enteral therapy in the region.

Extracorporeal Membrane Oxygenation Machine Market Size Worth $394.9 Million By 2027

The global extracorporeal membrane oxygenation machine market size is expected to reach USD 394.9 million by 2027, according to a new report by Grand View Research, Inc., registering a CAGR of 4.5% over the forecast period. The market is primarily driven by the increasing incidence of cardiopulmonary and respiratory diseases, and technological advancements in the field of extracorporeal membrane oxygenation (ECMO) procedures. Cardiovascular disease is one of the leading causes of death globally. According to WHO, 17.9 million people died from cardiovascular diseases in 2016. In addition, according to the Extracorporeal Life Support Organization, a total of 45,035 patients globally suffered from respiratory illnesses in 2016. Increasing awareness about ECMO procedures, coupled with various government initiatives, is further propelling the market for extracorporeal membrane oxygenation machines.

The increasing survival rate of cardiac and respiratory patients undergoing ECMO machine-supported surgery is also driving the ECMO machine market. The application of extracorporeal membrane oxygenation machine in procedures has increased over the years. This machine was traditionally used in cases of circulatory or respiratory failure. However, its applications have expanded to be used as rescue therapy for post-organ transplantation and sepsis and in cases of heart failure. The use of extracorporeal membrane oxygenation machines has been rising gradually worldwide owing to its benefits such as acting as an artificial lung for patients and growing awareness about its use. Moreover, increasing healthcare expenditure by government and private agencies in order to improve healthcare facilities are fueling the market for extracorporeal membrane oxygenation machines. According to the American Heart Association, medical expenditure related to CVDs is expected to reach USD 960 billion by 2030, rising from USD 320 billion in 2011.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/extracorporeal-membrane-oxygenation-ecmo-market

Further key findings from the study suggest:

By component, the oxygenators segment accounted for the leading revenue share in 2019 owing to its high cost and usage
Based on modality, veno-arterial ECMO machines held the dominant market share in 2019 and is also expected to register the fastest growth rate during the forecast period
On the basis of patient type, the adult segment is likely to exhibit a rapid pace over the course of the forecast period owing to the rising incidence of cardiac and pulmonary diseases
The respiratory application segment emerged as the leading revenue contributor in the ECMO machine market in 2019 and is also expected to grow at the fastest rate
North America accounted for the largest share in 2019 owing to favorable reimbursement policies, the presence of key players, and government initiatives
Leading players in the extracorporeal membrane oxygenation machines market include Nipro Medical Corporation Medtronic plc, Microport Scientific Corporation, Sorin Group, MAQUET Holding B.V. & Co. KG, Terumo Cardiovascular Systems Corporation, and Medos Medizintechnik AG. Major players are focusing on technological collaborations and product launches to stay ahead.